Trial intelligence / Profile preview

Carry Life UF System in CAPD Patients

NCT05874804Completed

Sponsor
Triomed
Start
Sep 2023
Primary completion
Oct 2025
Countries
3
01

Overview

Randomised, open-label trial (2 arms), sponsored by Triomed. Primary endpoint: Ultrafiltration volume at 8 weeks. Started Sep 2023; status: completed.

Beyond the preview

Go deeper on NCT05874804.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05874804.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call